Evidence map›Paper›PMID 40165166›Full record

ArticleBMC public health2025

Global, regional, and national burden of thyroid cancer in young people aged 10-24 years from 1990 to 2021: an analysis based on the Global Burden of Disease Study 2021.

Kaiyuan Huang, Ningxin Wang, Xuanwei Huang, Shuoying Qian, Yuan Cai, Fan Wu, Dingcun Luo

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Global, regional, and national burden and quality of care index of five head and neck cancers: a 32-year longitudinal analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaiyuan Huang *The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Zhejiang, Hangzhou, 310053, China.
Ningxin Wang *The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Zhejiang, Hangzhou, 310053, China.
Xuanwei HuangThe Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Zhejiang, Hangzhou, 310053, China.
Shuoying QianThe Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Zhejiang, Hangzhou, 310053, China.
Yuan CaiThe Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Zhejiang, Hangzhou, 310053, China.
Fan WuDepartment of Surgical Oncology,, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, 310006, China. docwf58@163.com.
Dingcun LuoThe Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Zhejiang, Hangzhou, 310053, China. ldc65@zju.edu.cn.

Funding

Zhejiang Medical and Health Science and Technology Plan Project 2022KY939
6 · The paper itself

Abstract

backgroundThe burden of thyroid cancer (TC) among young people aged 10-24 years has not been systematically studied to date. This study aims to analyze the burden of TC among young people aged 10-24 years globally, regionally, and nationally from 1990 to 2021.

methodsWe collected data on the incidence, mortality, and disability-adjusted life years (DALYs) rates for TC among young people aged 10-24 years from 1990 to 2021 using the Global Burden of Disease (GBD) 2021. Joinpoint regression analysis, frontier analysis, and health inequality analysis were employed to examine the variations and changes in TC burden among young people aged 10-24 years across different countries and regions.

resultsFrom 1990 to 2021, the global burden of TC among young people has increased from 2.726 per 100,000 people [95% Uncertainty Interval (UI) 2.38-3.181] to 2.956 per 100,000 people (95% UI: 2.339-3.922), with an Average Annual Percent Change (AAPC) of 0.258 (95% Confidence Interval (CI): 0.138-0.378). The highest incidence rates were observed in Saudi Arabia, Taiwan (China), and Vietnam, while the highest mortality rates were in India, China, and Bangladesh. Frontier analysis revealed that the largest disparities in effective differences were found in the Netherlands, Germany, Canada, the United States of America, and Guinea-Bissau. The Slope Index of Inequality (SII) for DALYs increased slightly from -0.15 in 1990 to -1.3 in 2021.

conclusionsOver the past three decades, the burden of TC has increased globally among young people, particularly in poorer countries and regions. This study highlights the importance of formulating public health policies tailored to the specific circumstances of different countries and regions aimed at reducing the TC burden among young people.

Indexed as

Global Burden of DiseaseGlobal HealthThyroid NeoplasmsAdolescentChildDisability-Adjusted Life YearsFemaleHumansIncidenceMaleYoung AdultDALYsGlobal disease burden 2021Health inequalityThyroid cancer

Identifiers

PMID40165166
PMCPMC11959951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.